Patient ID,Age,Gender,Tumor Type,Tumor Grade,Tumor Location,Treatment,Treatment Outcome,Time to Recurrence (months),Recurrence Site,Survival Time (months)
969,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
241,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
820,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
693,66,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Partial response,14.0,Temporal lobe,24
421,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1086,53,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Progressive disease,14.0,Parietal lobe,32
1999,62,Male,Astrocytoma,III,Frontal lobe,Radiation,Stable disease,22.0,Frontal lobe,28
366,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1023,61,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1241,49,Female,Astrocytoma,II,Occipital lobe,Radiation,Partial response,18.0,Occipital lobe,44
589,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
737,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,36
1762,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
942,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
72,48,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,48
1408,56,Female,Astrocytoma,III,Frontal lobe,Radiation,Stable disease,24.0,Frontal lobe,32
260,64,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,72
52,48,Male,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,24
199,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1789,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
651,55,Male,Astrocytoma,III,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
333,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1360,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,12.0,Parietal lobe,32
594,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1392,51,Female,Meningioma,I,Temporal lobe,Radiation,Complete response,,,36
1801,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
1315,49,Female,Meningioma,I,Temporal lobe,Radiation,Progressive disease,20.0,Temporal lobe,44
1112,55,Female,Meningioma,I,Frontal lobe,Surgery,Progressive disease,16.0,Frontal lobe,28
1007,60,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1327,64,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,16.0,Temporal lobe,44
427,55,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1559,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1294,48,Male,Astrocytoma,II,Occipital lobe,Chemotherapy,Stable disease,14.0,Occipital lobe,44
591,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1958,45,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,20.0,Temporal lobe,44
1977,61,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1133,54,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,16.0,Frontal lobe,28
986,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
399,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1512,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
437,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
193,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
1436,56,Female,Astrocytoma,III,Frontal lobe,Radiation,Stable disease,22.0,Frontal lobe,28
615,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Stable disease,18.0,Frontal lobe,36
1494,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
577,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
987,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1433,58,Male,Astrocytoma,II,Occipital lobe,Chemotherapy,Stable disease,20.0,Occipital lobe,32
707,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Partial response,20.0,Occipital lobe,48
1259,55,Female,Meningioma,I,Frontal lobe,Radiation,Progressive disease,20.0,Frontal lobe,28
142,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1358,53,Male,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,18.0,Occipital lobe,44
3,60,Male,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Progressive disease,14.0,Frontal lobe,22
1222,61,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Parietal lobe,32
1870,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1623,51,Male,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Partial response,18.0,Occipital lobe,30
340,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1770,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1537,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
484,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
266,54,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
377,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
742,50,Female,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,42
1014,64,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,18.0,Parietal lobe,32
440,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
272,49,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,48
185,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
940,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
245,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
932,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
446,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
597,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
818,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
1273,63,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Stable disease,20.0,Temporal lobe,28
1677,52,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,42
487,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
681,50,Male,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,24
416,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
274,60,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,8.0,Temporal lobe,12
1472,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1830,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1455,57,Male,Meningioma,I,Occipital lobe,Radiation,Progressive disease,12.0,Occipital lobe,32
251,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
414,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1386,61,Female,Meningioma,I,Parietal lobe,Chemotherapy,Progressive disease,14.0,Parietal lobe,44
1308,52,Male,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,18.0,Occipital lobe,44
716,54,Female,Astrocytoma,III,Temporal lobe,Surgery + Chemotherapy,Progressive disease,14.0,Temporal lobe,24
311,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
927,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
382,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1566,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Progressive disease,12.0,Occipital lobe,18
426,49,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,,,36
1875,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
533,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
753,51,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Stable disease,18.0,Temporal lobe,24
766,48,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,42
1357,62,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
409,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1615,58,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Stable disease,18.0,Temporal lobe,36
695,63,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1739,50,Male,Glioblastoma,III,Temporal lobe,Surgery + Radiation,Complete response,,,36
549,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
937,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1390,56,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,32
1608,66,Female,Astrocytoma,II,Frontal lobe,Surgery + Radiation,Partial response,12.0,Frontal lobe,24
1940,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
1482,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
183,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1941,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1161,64,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Stable disease,14.0,Frontal lobe,26
171,68,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,30
293,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
562,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1457,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
1877,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1652,65,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
850,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
273,55,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,24
1550,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1035,61,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,28
1744,61,Female,Astrocytoma,II,Frontal lobe,Surgery + Chemotherapy,Progressive disease,14.0,Frontal lobe,42
372,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1670,54,Female,Astrocytoma,III,Temporal lobe,Surgery + Chemotherapy,Progressive disease,14.0,Temporal lobe,24
722,66,Female,Astrocytoma,II,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
734,48,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Partial response,14.0,Parietal lobe,36
778,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,14.0,Frontal lobe,42
519,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
335,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
846,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
1252,57,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,32
1053,54,Female,Glioblastoma,IV,Frontal lobe,Surgery,Complete response,16.0,Frontal lobe,28
1924,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
16,52,Male,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Stable disease,18.0,Parietal lobe,36
708,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,36
901,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1980,57,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,38
1573,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
904,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
466,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1978,49,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,14.0,Temporal lobe,44
200,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1207,58,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1056,51,Male,Glioblastoma,IV,Temporal lobe,Surgery,Complete response,,,36
1132,67,Male,Meningioma,I,Temporal lobe,Chemotherapy,Progressive disease,14.0,Temporal lobe,44
1380,62,Female,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Progressive disease,14.0,Temporal lobe,32
999,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
728,53,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,30
1772,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
1910,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1822,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
568,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
44,70,Male,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,36
275,53,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,72
1097,66,Male,Meningioma,I,Frontal lobe,Radiation,Stable disease,12.0,Frontal lobe,28
102,54,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1232,50,Male,Meningioma,I,Frontal lobe,Chemotherapy,Progressive disease,16.0,Frontal lobe,28
1722,56,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Progressive disease,14.0,Occipital lobe,30
1833,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
108,58,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,24
1618,54,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Partial response,16.0,Occipital lobe,30
498,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1981,48,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Partial response,18.0,Occipital lobe,44
882,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
757,56,Male,Astrocytoma,III,Temporal lobe,Surgery + Chemotherapy,Complete response,,,30
620,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1107,48,Female,Astrocytoma,II,Occipital lobe,Chemotherapy,Partial response,18.0,Occipital lobe,44
1936,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
810,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
1038,63,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Stable disease,14.0,Temporal lobe,44
73,54,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,24
1284,57,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,38
1272,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,18.0,Parietal lobe,44
1335,63,Female,Astrocytoma,III,Temporal lobe,Surgery + Chemotherapy,Partial response,18.0,Temporal lobe,44
1459,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
482,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1069,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Progressive disease,12.0,Frontal lobe,32
507,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1238,52,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Stable disease,14.0,Temporal lobe,44
1862,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1990,53,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,32
1477,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1867,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1456,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
312,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
963,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
406,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1331,58,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Temporal lobe,36
1650,56,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
310,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
227,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1858,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
711,65,Female,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,42
1944,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
1384,53,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Partial response,12.0,Temporal lobe,32
1786,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
149,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1555,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Stable disease,18.0,Temporal lobe,36
1957,57,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
926,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
943,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
837,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
576,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
558,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1236,66,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,32
1361,65,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,24.0,Temporal lobe,38
1348,56,Male,Meningioma,I,Occipital lobe,Radiation,Stable disease,20.0,Occipital lobe,32
1162,49,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Parietal lobe,32
1443,48,Male,Meningioma,I,Occipital lobe,Chemotherapy,Progressive disease,14.0,Occipital lobe,44
287,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1605,55,Male,Astrocytoma,III,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
1058,55,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,16.0,Parietal lobe,32
599,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
933,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
1462,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1638,58,Female,Astrocytoma,II,Frontal lobe,Surgery + Chemotherapy,Partial response,16.0,Frontal lobe,42
1588,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1041,64,Male,Astrocytoma,III,Frontal lobe,Chemotherapy,Stable disease,14.0,Frontal lobe,26
1231,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,14.0,Occipital lobe,44
807,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
905,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
1680,50,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,14.0,Frontal lobe,24
1205,64,Female,Astrocytoma,III,Frontal lobe,Chemotherapy,Stable disease,22.0,Frontal lobe,28
768,56,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Progressive disease,14.0,Occipital lobe,30
610,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,16.0,Parietal lobe,24
1993,48,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,16.0,Frontal lobe,28
1565,55,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Complete response,,,48
1423,51,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,26.0,Temporal lobe,44
1011,59,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,38
494,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1321,54,Female,Meningioma,I,Frontal lobe,Chemotherapy,Complete response,,,38
278,54,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1847,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
359,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1111,50,Male,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,14.0,Occipital lobe,44
237,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
552,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1868,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
1813,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
209,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
1387,59,Male,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,36
1561,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Stable disease,14.0,Frontal lobe,30
59,49,Female,Glioblastoma,IV,Parietal lobe,Surgery,Partial response,16.0,Parietal lobe,30
632,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1962,47,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,18.0,Temporal lobe,44
1860,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
1817,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
364,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
506,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1166,53,Female,Glioblastoma,IV,Parietal lobe,Chemotherapy,Progressive disease,14.0,Parietal lobe,32
1122,49,Female,Meningioma,I,Parietal lobe,Chemotherapy,Progressive disease,18.0,Parietal lobe,32
1630,61,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Partial response,20.0,Frontal lobe,42
1217,62,Female,Meningioma,I,Frontal lobe,Radiation,Stable disease,12.0,Frontal lobe,28
1152,55,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,16.0,Frontal lobe,28
1125,62,Male,Astrocytoma,III,Frontal lobe,Chemotherapy,Stable disease,22.0,Frontal lobe,28
1595,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Stable disease,18.0,Temporal lobe,36
119,62,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,60
1250,58,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Parietal lobe,32
1994,57,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,38
523,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
514,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
82,67,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
916,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1019,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
381,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1030,59,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,38
1689,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,24
85,59,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1678,63,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Partial response,16.0,Occipital lobe,30
330,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
7,55,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,36
746,46,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Stable disease,20.0,Parietal lobe,42
1554,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
915,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
874,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
452,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
491,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1481,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
288,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
949,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
1986,55,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,16.0,Frontal lobe,28
1369,54,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,44
1147,48,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Partial response,18.0,Occipital lobe,44
706,55,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,18.0,Parietal lobe,42
1727,46,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,36
1702,54,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Complete response,,,36
1629,46,Male,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,24
1600,46,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Frontal lobe,42
1539,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1406,51,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,44
1651,50,Female,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Progressive disease,16.0,Temporal lobe,36
328,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
443,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
775,54,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,20.0,Parietal lobe,24
1088,47,Male,Astrocytoma,II,Temporal lobe,Surgery,Stable disease,18.0,Temporal lobe,44
1221,55,Female,Astrocytoma,III,Frontal lobe,Chemotherapy,Stable disease,20.0,Frontal lobe,28
1636,65,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Stable disease,18.0,Occipital lobe,30
178,54,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1323,63,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Stable disease,20.0,Temporal lobe,28
705,48,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Progressive disease,16.0,Temporal lobe,36
87,65,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1884,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
1948,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
458,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1829,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
55,51,Female,Astrocytoma,III,Temporal lobe,Surgery,Partial response,16.0,Temporal lobe,30
1502,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
644,53,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Partial response,16.0,Occipital lobe,30
678,59,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
222,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
114,48,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,10.0,Frontal lobe,18
983,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1229,54,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Progressive disease,12.0,Frontal lobe,32
1000,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
175,53,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,72
782,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Partial response,16.0,Frontal lobe,42
590,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1560,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,20.0,Parietal lobe,42
19,55,Female,Astrocytoma,II,Frontal lobe,Surgery,Complete response,,,60
424,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
1344,48,Male,Astrocytoma,II,Occipital lobe,Chemotherapy,Stable disease,14.0,Occipital lobe,44
286,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1584,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
429,46,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1510,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1319,55,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,44
670,56,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Temporal lobe,24
32,43,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Stable disease,36.0,Frontal lobe,48
941,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
723,52,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,42
995,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
215,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
814,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
327,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
561,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1113,58,Male,Glioblastoma,IV,Parietal lobe,Chemotherapy,Complete response,,,38
701,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,14.0,Temporal lobe,30
1579,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1190,59,Female,Meningioma,I,Parietal lobe,Radiation,Complete response,,,38
342,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
630,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
148,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1310,59,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,12.0,Parietal lobe,32
361,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
84,54,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
49,57,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,8.0,Parietal lobe,14
469,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
156,56,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
773,46,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,36
1240,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
1201,60,Female,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Stable disease,14.0,Frontal lobe,26
1403,61,Male,Astrocytoma,III,Frontal lobe,Chemotherapy,Stable disease,18.0,Frontal lobe,28
1203,47,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1631,54,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,48
501,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1765,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
180,47,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,22.0,Temporal lobe,36
1048,47,Male,Astrocytoma,II,Temporal lobe,Radiation,Stable disease,18.0,Temporal lobe,44
1756,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
951,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
1317,62,Female,Astrocytoma,II,Frontal lobe,Chemotherapy,Stable disease,16.0,Frontal lobe,32
1620,48,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,20.0,Temporal lobe,42
529,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
347,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1388,65,Female,Astrocytoma,III,Temporal lobe,Surgery + Chemotherapy,Stable disease,18.0,Temporal lobe,32
1961,60,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1051,59,Female,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,,,38
1973,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1442,64,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,24.0,Temporal lobe,38
602,50,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,48
1282,65,Male,Astrocytoma,II,Occipital lobe,Chemotherapy,Stable disease,14.0,Occipital lobe,44
244,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1337,51,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,36
1068,65,Male,Meningioma,I,Temporal lobe,Radiation,Stable disease,20.0,Temporal lobe,28
1476,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
313,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
436,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1899,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
1329,53,Female,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Partial response,18.0,Frontal lobe,28
309,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
431,67,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
661,58,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Stable disease,18.0,Temporal lobe,36
371,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
567,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
980,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
182,50,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,24
1363,57,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,36
622,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
819,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1193,58,Male,Glioblastoma,IV,Parietal lobe,Chemotherapy,Complete response,,,38
953,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1422,55,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,,,32
1841,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
923,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1074,46,Female,Astrocytoma,II,Temporal lobe,Radiation,Partial response,18.0,Temporal lobe,44
297,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
967,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
462,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1303,53,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,38
1177,66,Male,Meningioma,I,Frontal lobe,Radiation,Stable disease,12.0,Frontal lobe,28
378,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
799,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,20.0,Parietal lobe,30
1103,61,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,38
106,56,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
127,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1996,49,Female,Meningioma,I,Parietal lobe,Radiation,Progressive disease,18.0,Parietal lobe,32
839,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
356,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1617,61,Male,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,24
683,53,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
813,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
1681,65,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,42
210,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1493,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
141,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1975,63,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,28
1340,62,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1798,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1575,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1182,56,Female,Glioblastoma,IV,Parietal lobe,Chemotherapy,Progressive disease,12.0,Parietal lobe,32
1394,59,Female,Astrocytoma,II,Parietal lobe,Chemotherapy,Stable disease,22.0,Parietal lobe,28
1816,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
712,53,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Parietal lobe,30
1794,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
893,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
860,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
11,57,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,8.0,Parietal lobe,15
1695,56,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Complete response,,,36
1428,62,Female,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,32
283,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
811,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1342,49,Male,Meningioma,I,Parietal lobe,Radiation,Stable disease,20.0,Parietal lobe,32
292,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
755,52,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Partial response,14.0,Frontal lobe,36
627,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
944,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
862,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
130,47,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,22.0,Temporal lobe,36
1176,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,36
324,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1091,59,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,38
844,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
964,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1865,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
866,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
922,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
696,56,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
216,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1781,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1262,48,Male,Meningioma,I,Occipital lobe,Chemotherapy,Progressive disease,14.0,Occipital lobe,44
159,50,Female,Glioblastoma,IV,Parietal lobe,Surgery,Partial response,16.0,Parietal lobe,30
1059,58,Male,Glioblastoma,IV,Occipital lobe,Radiation,Complete response,,,38
989,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
842,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
635,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
517,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1429,50,Male,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,18.0,Occipital lobe,38
1748,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,42
598,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
196,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1784,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
870,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
411,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
97,45,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1001,62,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,14.0,Frontal lobe,26
1506,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
157,53,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,60
420,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1803,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
478,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
1856,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
669,51,Male,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Partial response,18.0,Occipital lobe,30
1418,54,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Frontal lobe,32
1872,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1300,59,Male,Astrocytoma,II,Parietal lobe,Chemotherapy,Stable disease,14.0,Parietal lobe,32
448,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
554,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
179,59,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
391,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
579,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1478,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1707,51,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Stable disease,18.0,Temporal lobe,24
1288,54,Male,Astrocytoma,II,Parietal lobe,Chemotherapy,Stable disease,14.0,Parietal lobe,32
1645,60,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,48
1024,49,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,14.0,Temporal lobe,44
821,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1825,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
985,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
1339,66,Female,Meningioma,I,Temporal lobe,Radiation,Progressive disease,16.0,Temporal lobe,44
665,59,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Complete response,,,36
143,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
1517,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1430,56,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Parietal lobe,44
865,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
422,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
637,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
1407,49,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,28
800,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1404,58,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,20.0,Frontal lobe,32
616,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Progressive disease,14.0,Occipital lobe,30
295,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
924,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1269,55,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,44
1903,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
89,62,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
42,52,Male,Meningioma,I,Occipital lobe,Surgery + Radiation,Progressive disease,18.0,Occipital lobe,30
1802,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1934,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
132,50,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,24
1002,49,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,18.0,Parietal lobe,32
1158,63,Male,Astrocytoma,III,Temporal lobe,Surgery,Stable disease,14.0,Temporal lobe,44
1095,57,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,20.0,Occipital lobe,38
1855,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1345,58,Female,Meningioma,I,Frontal lobe,Surgery,Progressive disease,16.0,Frontal lobe,28
1499,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
165,65,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,24
725,56,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,20.0,Temporal lobe,36
291,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1209,66,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,20.0,Frontal lobe,26
1589,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1897,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1642,59,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Partial response,18.0,Frontal lobe,42
1362,49,Male,Meningioma,I,Occipital lobe,Chemotherapy,Progressive disease,14.0,Occipital lobe,44
779,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,18.0,Parietal lobe,24
840,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
349,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1945,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
572,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
918,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
977,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1914,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1469,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1592,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1318,56,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,38
1845,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
137,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
459,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
376,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
1343,61,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Temporal lobe,36
334,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1160,57,Male,Glioblastoma,IV,Parietal lobe,Chemotherapy,Complete response,,,38
1761,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1458,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
817,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1115,61,Male,Meningioma,I,Frontal lobe,Radiation,Stable disease,20.0,Frontal lobe,28
1006,53,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,14.0,Parietal lobe,32
1857,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1955,62,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,14.0,Frontal lobe,26
1851,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
911,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
1930,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1126,53,Female,Glioblastoma,IV,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,32
329,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1248,54,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,44
319,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1690,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Stable disease,16.0,Occipital lobe,42
1359,56,Female,Meningioma,I,Frontal lobe,Radiation,Progressive disease,20.0,Frontal lobe,28
1733,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,18.0,Parietal lobe,24
168,46,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
13,70,Female,Astrocytoma,II,Temporal lobe,Surgery,Complete response,,,72
1927,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
172,49,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,48
650,48,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Complete response,,,36
1062,56,Female,Glioblastoma,IV,Parietal lobe,Radiation,Progressive disease,12.0,Parietal lobe,32
261,47,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,8.0,Occipital lobe,14
1367,61,Female,Astrocytoma,II,Frontal lobe,Chemotherapy,Stable disease,16.0,Frontal lobe,32
1549,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
902,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
673,53,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,16.0,Occipital lobe,36
259,50,Female,Glioblastoma,IV,Parietal lobe,Surgery,Partial response,16.0,Parietal lobe,30
845,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
868,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1800,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
139,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
894,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
1838,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
550,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
320,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1527,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1806,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1178,55,Female,Astrocytoma,II,Parietal lobe,Chemotherapy,Progressive disease,16.0,Parietal lobe,32
559,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
140,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1735,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Stable disease,12.0,Temporal lobe,36
532,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
225,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
724,63,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Partial response,16.0,Occipital lobe,30
787,53,Male,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,24
1718,54,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Partial response,18.0,Occipital lobe,30
1008,47,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,18.0,Temporal lobe,44
410,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
326,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1766,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
300,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1263,57,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,36
1946,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
26,46,Male,Glioblastoma,IV,Frontal lobe,Surgery,Partial response,20.0,Temporal lobe,24
1859,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
715,61,Male,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,48
1010,50,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,22.0,Parietal lobe,32
194,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
441,48,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
574,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
947,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
998,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
504,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
606,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,20.0,Parietal lobe,42
1717,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,42
1164,45,Female,Meningioma,I,Temporal lobe,Chemotherapy,Partial response,20.0,Temporal lobe,44
1787,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
847,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
4,50,Female,Glioblastoma,IV,Temporal lobe,Surgery + Radiation therapy,Complete response,,,12
1287,51,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,36
1223,52,Female,Meningioma,I,Occipital lobe,Radiation,Complete response,,,38
468,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
322,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
6,45,Male,Glioblastoma,IV,Frontal lobe,Surgery,Partial response,10.0,Temporal lobe,18
223,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1375,49,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Stable disease,16.0,Frontal lobe,28
548,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
229,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
40,53,Male,Astrocytoma,III,Frontal lobe,Surgery,Stable disease,20.0,Frontal lobe,42
543,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
243,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
899,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1134,64,Male,Meningioma,I,Parietal lobe,Chemotherapy,Stable disease,18.0,Parietal lobe,32
1449,56,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,38
1869,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
843,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1419,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,14.0,Temporal lobe,38
1654,58,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,42
1970,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
662,46,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,42
1211,60,Female,Astrocytoma,III,Occipital lobe,Radiation,Stable disease,,,38
315,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
692,51,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Stable disease,20.0,Frontal lobe,42
1504,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
425,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
595,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1964,50,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,22.0,Parietal lobe,32
623,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1171,59,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Stable disease,,,38
1044,45,Female,Meningioma,I,Temporal lobe,Chemotherapy,Partial response,20.0,Temporal lobe,44
228,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,22.0,Temporal lobe,36
1118,63,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Stable disease,14.0,Temporal lobe,44
1332,65,Male,Astrocytoma,II,Occipital lobe,Chemotherapy,Stable disease,14.0,Occipital lobe,44
1316,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,12.0,Occipital lobe,28
67,58,Female,Astrocytoma,II,Parietal lobe,Surgery,Partial response,22.0,Parietal lobe,42
25,72,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,10.0,Temporal lobe,18
145,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
537,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
812,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1467,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
86,47,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,22.0,Temporal lobe,36
1661,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Partial response,20.0,Occipital lobe,48
1646,51,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Stable disease,20.0,Frontal lobe,42
1805,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1818,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1577,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1145,54,Female,Meningioma,I,Frontal lobe,Chemotherapy,Progressive disease,16.0,Frontal lobe,28
363,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1612,50,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1866,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1027,48,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Partial response,18.0,Occipital lobe,44
1031,50,Male,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,14.0,Occipital lobe,44
1304,49,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,44
1356,64,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Progressive disease,14.0,Temporal lobe,32
1731,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Partial response,12.0,Temporal lobe,36
666,48,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,20.0,Temporal lobe,42
365,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
78,63,Male,Meningioma,I,Temporal lobe,Surgery,Complete response,,,60
28,59,Male,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Progressive disease,8.0,Occipital lobe,12
1437,63,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Progressive disease,14.0,Temporal lobe,32
526,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1835,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
56,55,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
639,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
303,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
719,55,Male,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,20.0,Occipital lobe,42
625,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
8,60,Male,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Progressive disease,14.0,Frontal lobe,22
804,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1050,50,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,22.0,Parietal lobe,32
337,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
48,46,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Complete response,,,60
1764,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
107,53,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,60
350,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1080,57,Male,Glioblastoma,IV,Parietal lobe,Chemotherapy,Complete response,,,38
239,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
214,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1776,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1139,58,Male,Glioblastoma,IV,Occipital lobe,Chemotherapy,Complete response,,,38
794,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,42
1587,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1583,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1672,48,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,36
524,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
233,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
645,58,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,14.0,Temporal lobe,36
1508,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
534,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1942,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
604,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Partial response,16.0,Occipital lobe,30
1330,56,Male,Meningioma,I,Parietal lobe,Radiation,Stable disease,20.0,Parietal lobe,32
1075,61,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Stable disease,20.0,Frontal lobe,28
1305,56,Female,Astrocytoma,III,Frontal lobe,Radiation,Stable disease,22.0,Frontal lobe,28
61,46,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,8.0,Occipital lobe,14
1264,53,Male,Astrocytoma,III,Parietal lobe,Surgery + Chemotherapy,Stable disease,18.0,Parietal lobe,32
93,53,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,48
667,55,Male,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Stable disease,14.0,Frontal lobe,24
281,65,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1114,46,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Partial response,18.0,Temporal lobe,44
360,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1129,62,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Frontal lobe,26
1170,50,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,22.0,Parietal lobe,32
848,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1522,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
111,47,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,8.0,Occipital lobe,14
43,44,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Partial response,16.0,Temporal lobe,24
126,68,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,12.0,Frontal lobe,18
205,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
53,54,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,36
546,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
69,61,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,60
1741,53,Male,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,24
1548,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
184,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
138,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
900,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
797,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
133,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
81,51,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1987,58,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
1541,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
542,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1669,61,Male,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,48
984,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
166,54,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
249,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
447,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1515,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
859,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1212,59,Male,Meningioma,I,Temporal lobe,Chemotherapy,Progressive disease,14.0,Temporal lobe,44
98,58,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1974,47,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,44
738,66,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Progressive disease,20.0,Parietal lobe,42
1256,63,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Progressive disease,14.0,Temporal lobe,32
103,59,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,12.0,Parietal lobe,24
435,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
75,52,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,72
1792,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1235,63,Female,Meningioma,I,Frontal lobe,Chemotherapy,Stable disease,20.0,Frontal lobe,28
919,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1712,50,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,18.0,Parietal lobe,36
1671,59,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Stable disease,18.0,Parietal lobe,30
1621,55,Male,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Stable disease,14.0,Frontal lobe,24
763,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,42
990,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
389,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
236,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1507,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
268,46,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1188,65,Male,Meningioma,I,Temporal lobe,Chemotherapy,Stable disease,20.0,Temporal lobe,28
118,46,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1607,51,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Stable disease,20.0,Temporal lobe,36
674,58,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
250,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1453,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,18.0,Parietal lobe,44
1995,64,Male,Astrocytoma,III,Frontal lobe,Chemotherapy,Stable disease,14.0,Frontal lobe,26
95,49,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
34,48,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,14.0,Occipital lobe,30
1464,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1668,46,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Partial response,16.0,Temporal lobe,42
449,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
717,59,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Stable disease,18.0,Parietal lobe,30
1810,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1518,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
1,45,Male,Glioblastoma,IV,Frontal lobe,Surgery,Partial response,10.0,Temporal lobe,18
1376,50,Female,Astrocytoma,II,Occipital lobe,Chemotherapy,Progressive disease,20.0,Occipital lobe,32
1102,56,Female,Glioblastoma,IV,Parietal lobe,Chemotherapy,Progressive disease,12.0,Parietal lobe,32
1109,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Progressive disease,12.0,Frontal lobe,32
1227,53,Female,Astrocytoma,II,Occipital lobe,Chemotherapy,Partial response,18.0,Occipital lobe,44
83,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1289,66,Female,Meningioma,I,Temporal lobe,Radiation,Progressive disease,16.0,Temporal lobe,44
677,54,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,48
1921,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1047,60,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
771,53,Male,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,24
1947,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1281,58,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Temporal lobe,36
1581,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1489,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
405,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1728,61,Female,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,42
1299,54,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,36
1341,55,Female,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Partial response,18.0,Frontal lobe,28
105,65,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Partial response,18.0,Occipital lobe,36
689,48,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Stable disease,12.0,Temporal lobe,30
1306,63,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Progressive disease,14.0,Temporal lobe,32
827,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
63,69,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,48
853,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1354,51,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,44
224,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
146,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1089,62,Female,Meningioma,I,Frontal lobe,Radiation,Progressive disease,20.0,Frontal lobe,26
374,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1421,60,Male,Meningioma,I,Parietal lobe,Radiation,Progressive disease,12.0,Parietal lobe,28
1143,61,Female,Meningioma,I,Occipital lobe,Chemotherapy,Complete response,,,38
1827,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
1495,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1602,54,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,12.0,Occipital lobe,18
1271,54,Female,Meningioma,I,Frontal lobe,Chemotherapy,Complete response,,,38
10,65,Male,Astrocytoma,II,Frontal lobe,Surgery + Radiation,Partial response,24.0,Frontal lobe,48
450,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
709,56,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,14.0,Frontal lobe,30
256,56,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
883,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
390,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
909,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
925,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1704,48,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Partial response,16.0,Parietal lobe,30
1233,59,Female,Glioblastoma,IV,Parietal lobe,Radiation,Complete response,,,38
461,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1270,50,Male,Astrocytoma,III,Occipital lobe,Radiation,Progressive disease,16.0,Occipital lobe,28
1760,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1169,62,Female,Meningioma,I,Frontal lobe,Chemotherapy,Progressive disease,20.0,Frontal lobe,26
959,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
502,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
740,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Partial response,14.0,Occipital lobe,24
1850,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
869,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
732,54,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Complete response,,,36
540,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
1202,55,Male,Meningioma,I,Parietal lobe,Chemotherapy,Progressive disease,18.0,Parietal lobe,32
698,65,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
1393,63,Male,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,18.0,Occipital lobe,44
1377,61,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,38
1146,57,Male,Glioblastoma,IV,Parietal lobe,Radiation,Complete response,,,38
1032,55,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,16.0,Frontal lobe,28
373,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
668,60,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,42
1526,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
358,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
968,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
784,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Stable disease,18.0,Occipital lobe,30
736,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Stable disease,16.0,Occipital lobe,42
1036,53,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,32
971,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1525,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1487,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1524,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1491,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1643,48,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Stable disease,12.0,Temporal lobe,30
1253,53,Female,Glioblastoma,IV,Parietal lobe,Chemotherapy,Complete response,,,38
1694,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Partial response,14.0,Occipital lobe,24
1750,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,14.0,Occipital lobe,30
1237,55,Female,Meningioma,I,Occipital lobe,Chemotherapy,Complete response,,,38
886,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
80,58,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,14.0,Frontal lobe,30
1173,54,Female,Glioblastoma,IV,Frontal lobe,Chemotherapy,Complete response,16.0,Frontal lobe,28
815,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
1286,59,Male,Meningioma,I,Occipital lobe,Radiation,Stable disease,20.0,Occipital lobe,32
672,65,Female,Astrocytoma,II,Frontal lobe,Surgery + Radiation,Complete response,,,48
1532,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
58,57,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,24
134,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1141,63,Male,Astrocytoma,III,Frontal lobe,Chemotherapy,Stable disease,20.0,Frontal lobe,28
934,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
1685,61,Male,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,20.0,Parietal lobe,24
824,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1215,56,Female,Astrocytoma,II,Occipital lobe,Chemotherapy,Progressive disease,20.0,Occipital lobe,38
505,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
1775,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
348,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
387,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1025,54,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,16.0,Frontal lobe,28
895,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
829,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
1893,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
476,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
1471,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1448,62,Female,Astrocytoma,II,Frontal lobe,Chemotherapy,Stable disease,16.0,Frontal lobe,32
1582,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
653,51,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Stable disease,20.0,Temporal lobe,36
173,55,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,24
1150,59,Female,Meningioma,I,Parietal lobe,Radiation,Complete response,,,38
39,47,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,60
714,46,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Partial response,16.0,Temporal lobe,42
91,69,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
1937,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1206,45,Male,Glioblastoma,IV,Parietal lobe,Radiation,Progressive disease,14.0,Parietal lobe,32
876,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1352,60,Male,Astrocytoma,II,Occipital lobe,Chemotherapy,Stable disease,20.0,Occipital lobe,32
1890,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1094,64,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Stable disease,18.0,Parietal lobe,32
1156,53,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,32
1782,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1959,64,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,22.0,Frontal lobe,28
500,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
339,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1189,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,32
29,51,Female,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1218,49,Male,Astrocytoma,II,Parietal lobe,Chemotherapy,Progressive disease,16.0,Parietal lobe,32
1400,64,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Partial response,20.0,Temporal lobe,32
1821,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
946,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
170,51,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,36
1405,63,Male,Astrocytoma,II,Occipital lobe,Chemotherapy,Stable disease,22.0,Occipital lobe,38
1198,63,Male,Astrocytoma,III,Temporal lobe,Surgery,Stable disease,14.0,Temporal lobe,44
1254,49,Male,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Partial response,16.0,Occipital lobe,44
1614,53,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,14.0,Occipital lobe,30
913,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
492,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
954,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
1098,55,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Progressive disease,16.0,Parietal lobe,32
1033,58,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
588,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
751,55,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Frontal lobe,36
658,50,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
235,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
733,59,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Stable disease,18.0,Temporal lobe,30
1989,61,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,28
1633,48,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,16.0,Temporal lobe,30
1157,56,Female,Meningioma,I,Occipital lobe,Chemotherapy,Complete response,,,38
1470,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
1425,59,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,14.0,Parietal lobe,38
1628,58,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
935,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
1210,51,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,22.0,Parietal lobe,32
1066,57,Male,Glioblastoma,IV,Parietal lobe,Surgery,Complete response,,,38
109,50,Female,Glioblastoma,IV,Parietal lobe,Surgery,Partial response,16.0,Parietal lobe,30
1543,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
569,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1168,47,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,18.0,Temporal lobe,44
1175,57,Female,Astrocytoma,II,Occipital lobe,Chemotherapy,Progressive disease,20.0,Occipital lobe,38
891,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
948,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1049,62,Female,Meningioma,I,Frontal lobe,Surgery,Progressive disease,20.0,Frontal lobe,26
1353,55,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,38
1778,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1447,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,12.0,Occipital lobe,28
885,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1673,55,Male,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,20.0,Occipital lobe,42
851,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
735,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,24
718,48,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,36
455,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
265,65,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,24
76,66,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,12.0,Frontal lobe,18
1658,59,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Complete response,,,30
445,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
396,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
177,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1043,57,Male,Glioblastoma,IV,Occipital lobe,Surgery,Complete response,,,38
1736,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Partial response,16.0,Frontal lobe,42
1402,55,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,44
1381,52,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
596,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
62,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,20.0,Temporal lobe,42
1297,63,Female,Astrocytoma,III,Temporal lobe,Surgery + Chemotherapy,Partial response,18.0,Temporal lobe,44
873,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
1490,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1879,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
279,59,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
37,50,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,12
1976,56,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,32
663,61,Male,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,24
1954,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1445,53,Male,Astrocytoma,III,Parietal lobe,Surgery + Chemotherapy,Stable disease,18.0,Parietal lobe,32
978,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
1572,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,42
739,52,Male,Astrocytoma,II,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,30
192,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
920,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
457,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
676,61,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Partial response,20.0,Frontal lobe,42
761,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,20.0,Temporal lobe,36
1808,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1603,59,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,24
729,58,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,12.0,Temporal lobe,36
413,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
1099,58,Male,Glioblastoma,IV,Occipital lobe,Chemotherapy,Complete response,,,38
826,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
1640,61,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
617,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
115,65,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,24
418,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1911,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
970,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
605,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1919,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
90,55,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
849,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1520,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1918,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
754,66,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
499,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1277,64,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,16.0,Temporal lobe,44
1326,49,Male,Astrocytoma,III,Parietal lobe,Chemotherapy,Stable disease,14.0,Parietal lobe,32
12,48,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Complete response,,,60
397,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
285,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
1067,48,Female,Astrocytoma,II,Occipital lobe,Chemotherapy,Partial response,18.0,Occipital lobe,44
1192,55,Female,Meningioma,I,Frontal lobe,Surgery,Progressive disease,16.0,Frontal lobe,28
1745,54,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,18.0,Parietal lobe,24
691,60,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,48
1753,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,20.0,Parietal lobe,30
1876,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
690,55,Female,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,36
852,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
160,64,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,72
896,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1576,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
258,58,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,24
336,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1880,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1040,57,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,38
516,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
1349,54,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,36
1016,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
769,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,36
1747,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,20.0,Temporal lobe,36
762,46,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Stable disease,14.0,Parietal lobe,24
1247,56,Female,Glioblastoma,IV,Parietal lobe,Radiation,Complete response,,,38
1204,52,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Partial response,20.0,Temporal lobe,44
1468,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1984,59,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,38
522,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
23,61,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,24
357,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1278,60,Male,Glioblastoma,IV,Occipital lobe,Chemotherapy,Complete response,,,38
1313,57,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,36
1683,58,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,12.0,Temporal lobe,36
341,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
432,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
474,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
218,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
912,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1228,65,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Stable disease,20.0,Temporal lobe,28
1597,65,Male,Astrocytoma,III,Parietal lobe,Surgery + Chemotherapy,Complete response,,,42
1012,67,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,14.0,Temporal lobe,44
1950,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
94,57,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,20.0,Temporal lobe,36
1009,62,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Frontal lobe,26
1071,50,Male,Astrocytoma,III,Occipital lobe,Surgery,Stable disease,14.0,Occipital lobe,44
1093,54,Female,Glioblastoma,IV,Frontal lobe,Chemotherapy,Complete response,16.0,Frontal lobe,28
1915,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1309,55,Female,Meningioma,I,Frontal lobe,Radiation,Progressive disease,20.0,Frontal lobe,28
697,50,Female,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Progressive disease,16.0,Temporal lobe,36
1828,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
997,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
154,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,22.0,Temporal lobe,36
1100,47,Female,Meningioma,I,Temporal lobe,Surgery,Partial response,18.0,Temporal lobe,44
1719,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,36
1998,45,Female,Meningioma,I,Temporal lobe,Chemotherapy,Partial response,20.0,Temporal lobe,44
790,61,Female,Astrocytoma,II,Frontal lobe,Surgery + Chemotherapy,Progressive disease,14.0,Frontal lobe,42
581,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
704,59,Male,Meningioma,I,Frontal lobe,Surgery + Radiation,Complete response,,,30
1213,50,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,16.0,Frontal lobe,28
1296,50,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,38
1666,53,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Parietal lobe,30
1261,64,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,22.0,Temporal lobe,38
488,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
560,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1142,56,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Parietal lobe,32
1120,57,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
802,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
513,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
634,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1922,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1788,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
1546,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
1151,50,Male,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,14.0,Occipital lobe,44
791,54,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,18.0,Parietal lobe,24
117,59,Female,Astrocytoma,II,Parietal lobe,Surgery,Partial response,22.0,Parietal lobe,42
741,56,Male,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Complete response,,,36
1691,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,36
1082,49,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Progressive disease,18.0,Parietal lobe,32
831,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
120,51,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,36
657,56,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1908,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
636,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
370,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
269,62,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,60
656,63,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Progressive disease,18.0,Occipital lobe,36
936,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
823,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
867,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
47,63,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Partial response,10.0,Temporal lobe,12
1374,56,Male,Meningioma,I,Occipital lobe,Radiation,Progressive disease,12.0,Occipital lobe,32
1709,52,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Partial response,14.0,Frontal lobe,36
992,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
877,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
774,61,Female,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,42
1220,63,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,44
2000,53,Female,Glioblastoma,IV,Parietal lobe,Chemotherapy + Radiation,Progressive disease,14.0,Parietal lobe,32
5,65,Male,Astrocytoma,II,Frontal lobe,Surgery + Radiation therapy,Partial response,24.0,Frontal lobe,48
1004,45,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,20.0,Temporal lobe,44
1724,65,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,42
264,48,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,10.0,Frontal lobe,18
1570,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Progressive disease,14.0,Occipital lobe,30
1831,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
444,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1003,57,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1078,63,Male,Astrocytoma,III,Temporal lobe,Radiation,Stable disease,14.0,Temporal lobe,44
838,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1791,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
305,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1366,57,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,12.0,Occipital lobe,28
1558,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Partial response,16.0,Occipital lobe,30
314,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
150,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1149,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,32
1214,67,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,18.0,Parietal lobe,32
575,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
51,66,Female,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Complete response,,,72
1553,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
727,65,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,42
834,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
1378,58,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,44
1116,53,Female,Glioblastoma,IV,Parietal lobe,Surgery,Progressive disease,12.0,Parietal lobe,32
1167,60,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
471,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
972,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
654,66,Female,Astrocytoma,II,Frontal lobe,Surgery + Radiation,Partial response,12.0,Frontal lobe,24
400,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
512,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
321,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
20,68,Male,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,9.0,Occipital lobe,14
685,46,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Stable disease,20.0,Temporal lobe,48
36,62,Male,Astrocytoma,III,Parietal lobe,Surgery,Progressive disease,10.0,Parietal lobe,18
903,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1779,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
828,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1854,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
408,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
921,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
538,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
759,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1905,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
1063,61,Female,Meningioma,I,Occipital lobe,Chemotherapy,Complete response,,,38
1200,57,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
246,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1417,62,Male,Astrocytoma,III,Parietal lobe,Chemotherapy,Stable disease,18.0,Parietal lobe,38
1128,47,Male,Astrocytoma,II,Temporal lobe,Chemotherapy,Stable disease,18.0,Temporal lobe,44
785,50,Male,Glioblastoma,III,Temporal lobe,Surgery + Radiation,Complete response,,,36
1743,46,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
490,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
155,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
962,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
854,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1312,48,Male,Meningioma,I,Occipital lobe,Chemotherapy,Progressive disease,14.0,Occipital lobe,44
626,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
686,61,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
1562,54,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
570,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1909,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
18,47,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
128,54,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1347,63,Female,Astrocytoma,III,Temporal lobe,Surgery + Chemotherapy,Partial response,18.0,Temporal lobe,44
1280,56,Male,Meningioma,I,Parietal lobe,Radiation,Stable disease,20.0,Parietal lobe,32
1969,57,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,20.0,Occipital lobe,38
928,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
981,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1965,59,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,38
191,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1140,47,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,44
993,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1956,49,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,18.0,Parietal lobe,32
1657,54,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Stable disease,12.0,Occipital lobe,24
607,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Stable disease,14.0,Frontal lobe,30
181,65,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
302,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
497,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1721,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,24
1710,63,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Stable disease,16.0,Occipital lobe,42
1888,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
1992,63,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Stable disease,14.0,Temporal lobe,44
518,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1985,50,Male,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,14.0,Occipital lobe,44
1070,59,Female,Meningioma,I,Parietal lobe,Chemotherapy,Complete response,,,38
477,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
158,58,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,24
1244,53,Male,Meningioma,I,Parietal lobe,Chemotherapy,Complete response,,,38
1196,53,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,32
17,63,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Partial response,6.0,Frontal lobe,9
1536,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1073,58,Male,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
1972,55,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,32
547,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1540,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
659,65,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,24
1626,65,Female,Astrocytoma,II,Frontal lobe,Surgery + Radiation,Complete response,,,48
1020,47,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,44
1663,56,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,14.0,Frontal lobe,30
1505,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
960,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1882,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
284,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
798,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,42
1627,53,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,16.0,Occipital lobe,36
226,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
27,54,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,48
1771,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
438,66,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1949,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1389,48,Male,Meningioma,I,Occipital lobe,Radiation,Progressive disease,16.0,Occipital lobe,28
230,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,24
38,65,Male,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Partial response,24.0,Occipital lobe,36
750,48,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Partial response,16.0,Parietal lobe,30
1046,53,Female,Glioblastoma,IV,Parietal lobe,Chemotherapy + Radiation,Progressive disease,14.0,Parietal lobe,32
1399,53,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,28
470,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1693,52,Male,Astrocytoma,II,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,30
1968,64,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,18.0,Parietal lobe,32
688,59,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Partial response,18.0,Frontal lobe,42
1844,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
640,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1713,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1219,58,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1159,48,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,16.0,Frontal lobe,28
1416,58,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,32
1528,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1656,61,Male,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,18.0,Parietal lobe,36
1301,61,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,16.0,Frontal lobe,28
1823,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
801,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1604,48,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Complete response,,,36
161,47,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,8.0,Occipital lobe,14
957,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1187,48,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Partial response,18.0,Occipital lobe,44
822,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1682,53,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,30
878,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
914,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
153,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1871,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1777,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
510,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1136,51,Male,Glioblastoma,IV,Temporal lobe,Chemotherapy,Complete response,,,36
1251,48,Female,Meningioma,I,Frontal lobe,Surgery,Stable disease,14.0,Frontal lobe,28
1684,46,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,42
104,47,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1446,49,Female,Meningioma,I,Temporal lobe,Radiation,Progressive disease,20.0,Temporal lobe,44
1444,57,Female,Glioblastoma,IV,Frontal lobe,Surgery + Radiation,Complete response,,,36
587,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1769,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
1144,49,Male,Astrocytoma,II,Temporal lobe,Surgery,Stable disease,14.0,Temporal lobe,44
54,60,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Stable disease,24.0,Parietal lobe,48
152,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
404,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1943,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
208,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1895,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1123,57,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1891,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
9,50,Female,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,12
1015,57,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,20.0,Occipital lobe,38
1907,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1061,63,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Stable disease,20.0,Frontal lobe,28
453,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
254,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,24
1328,60,Male,Glioblastoma,IV,Occipital lobe,Chemotherapy,Complete response,,,38
897,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1734,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Complete response,,,30
881,65,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1596,50,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,24
1889,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
624,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
346,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1703,59,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,12.0,Temporal lobe,24
263,70,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,48
1635,50,Male,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,24
1322,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,18.0,Parietal lobe,44
1439,52,Male,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,18.0,Occipital lobe,44
151,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
473,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
641,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Stable disease,18.0,Temporal lobe,36
1983,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,32
1883,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
551,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
1780,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
929,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
489,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
1812,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
1172,67,Male,Meningioma,I,Temporal lobe,Chemotherapy,Progressive disease,14.0,Temporal lobe,44
147,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
1705,55,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Frontal lobe,36
1929,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
403,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
955,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1878,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
660,53,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,14.0,Occipital lobe,30
1373,63,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Stable disease,20.0,Temporal lobe,28
464,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1350,59,Male,Astrocytoma,II,Parietal lobe,Chemotherapy,Stable disease,14.0,Parietal lobe,32
187,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1148,65,Male,Meningioma,I,Temporal lobe,Chemotherapy,Stable disease,20.0,Temporal lobe,28
1225,48,Female,Meningioma,I,Frontal lobe,Chemotherapy,Progressive disease,16.0,Frontal lobe,28
609,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Temporal lobe,42
144,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
752,60,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Complete response,,,42
1535,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
982,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
198,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1634,55,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Partial response,18.0,Frontal lobe,36
884,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
280,47,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,22.0,Temporal lobe,36
294,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1824,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
401,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
123,55,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,24
1208,53,Male,Astrocytoma,II,Temporal lobe,Chemotherapy,Stable disease,18.0,Temporal lobe,44
203,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1463,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
836,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
247,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1440,55,Female,Meningioma,I,Frontal lobe,Radiation,Progressive disease,20.0,Frontal lobe,28
1754,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1902,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1708,66,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1881,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1154,46,Female,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Partial response,18.0,Temporal lobe,44
1662,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,36
1427,57,Male,Meningioma,I,Frontal lobe,Radiation,Progressive disease,12.0,Frontal lobe,28
385,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1759,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
855,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1590,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
220,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
642,50,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,24
2,55,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,36
113,70,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,48
699,53,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Complete response,,,48
1916,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
952,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1649,63,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1637,53,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1886,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1411,54,Male,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,18.0,Occipital lobe,28
1410,59,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,44
1534,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
1292,49,Male,Meningioma,I,Parietal lobe,Radiation,Stable disease,20.0,Parietal lobe,32
1809,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
442,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1521,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1137,66,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,28
1716,46,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Stable disease,14.0,Parietal lobe,24
1257,61,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
1864,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Stable disease,16.0,Parietal lobe,30
1632,59,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1696,50,Female,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,42
1398,57,Female,Meningioma,I,Parietal lobe,Radiation,Complete response,,,36
664,54,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Partial response,16.0,Occipital lobe,30
1836,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
1258,52,Male,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,18.0,Occipital lobe,44
1774,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1701,61,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,14.0,Frontal lobe,30
318,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
649,59,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,24
1435,49,Male,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,44
1480,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
710,50,Male,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Stable disease,18.0,Occipital lobe,36
1383,57,Male,Meningioma,I,Frontal lobe,Radiation,Progressive disease,20.0,Frontal lobe,28
1283,48,Female,Meningioma,I,Frontal lobe,Surgery,Progressive disease,16.0,Frontal lobe,28
973,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
628,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
633,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1307,61,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
1401,50,Male,Meningioma,I,Occipital lobe,Radiation,Stable disease,14.0,Occipital lobe,38
1409,61,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Progressive disease,16.0,Temporal lobe,38
1249,62,Female,Meningioma,I,Frontal lobe,Chemotherapy,Stable disease,20.0,Frontal lobe,28
1953,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
1255,58,Female,Astrocytoma,II,Frontal lobe,Radiation,Stable disease,20.0,Frontal lobe,28
1497,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1372,58,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,18.0,Parietal lobe,44
1530,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1664,50,Male,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Stable disease,18.0,Occipital lobe,36
1355,58,Female,Astrocytoma,III,Frontal lobe,Radiation,Stable disease,22.0,Frontal lobe,28
1926,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1901,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
1644,55,Female,Astrocytoma,III,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,36
1849,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
796,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,14.0,Occipital lobe,30
646,46,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,20.0,Frontal lobe,42
1013,54,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,16.0,Frontal lobe,28
1840,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
557,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
682,65,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Stable disease,18.0,Occipital lobe,30
578,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1110,59,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
1267,62,Female,Astrocytoma,II,Frontal lobe,Chemotherapy,Stable disease,16.0,Frontal lobe,32
1723,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,36
1184,49,Male,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,44
525,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1060,47,Female,Meningioma,I,Temporal lobe,Chemotherapy,Partial response,18.0,Temporal lobe,44
541,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1195,61,Male,Meningioma,I,Frontal lobe,Chemotherapy,Stable disease,20.0,Frontal lobe,28
1679,56,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,20.0,Temporal lobe,36
749,59,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,12.0,Temporal lobe,24
1852,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
1431,54,Male,Astrocytoma,II,Frontal lobe,Radiation,Stable disease,14.0,Frontal lobe,28
485,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1758,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
96,63,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1021,63,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,28
564,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
1265,49,Female,Meningioma,I,Temporal lobe,Radiation,Progressive disease,20.0,Temporal lobe,44
743,65,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,24
864,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1599,58,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,14.0,Temporal lobe,36
1715,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,20.0,Temporal lobe,36
1485,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
892,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1578,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1039,48,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,16.0,Frontal lobe,28
207,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
393,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
795,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,12.0,Parietal lobe,24
871,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
398,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
767,63,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,24
1842,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1242,57,Male,Meningioma,I,Temporal lobe,Chemotherapy,Stable disease,20.0,Temporal lobe,28
1029,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,12.0,Frontal lobe,32
1793,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
643,65,Male,Astrocytoma,III,Parietal lobe,Surgery + Chemotherapy,Complete response,,,42
1892,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
613,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,24
1763,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
961,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,24
1571,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
726,50,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,14.0,Frontal lobe,24
684,58,Female,Astrocytoma,II,Frontal lobe,Surgery + Chemotherapy,Partial response,16.0,Frontal lobe,42
99,51,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
805,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
1752,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,42
1598,53,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Partial response,16.0,Occipital lobe,30
407,55,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
503,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
1072,55,Female,Meningioma,I,Frontal lobe,Chemotherapy,Progressive disease,16.0,Frontal lobe,28
1057,66,Male,Meningioma,I,Frontal lobe,Chemotherapy,Stable disease,12.0,Frontal lobe,28
930,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
780,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Complete response,,,30
201,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
135,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,18.0,Parietal lobe,42
1052,67,Male,Meningioma,I,Temporal lobe,Radiation,Progressive disease,14.0,Temporal lobe,44
41,69,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Complete response,,,24
1018,55,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,32
231,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1514,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
1797,51,Female,Astrocytoma,III,Occipital lobe,Surgery + Chemotherapy,Stable disease,,,36
379,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
289,51,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
419,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1699,58,Male,Astrocytoma,II,Temporal lobe,Surgery + Chemotherapy,Partial response,18.0,Temporal lobe,36
392,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
593,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1523,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1163,57,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,38
1087,60,Female,Meningioma,I,Occipital lobe,Chemotherapy,Complete response,,,38
1496,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
648,54,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,12.0,Occipital lobe,18
1153,58,Male,Glioblastoma,IV,Parietal lobe,Chemotherapy,Complete response,,,38
1368,55,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,38
521,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
1863,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
65,65,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,24
1837,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
15,58,Female,Meningioma,I,Temporal lobe,Surgery,Complete response,,,42
1181,63,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,28
1065,54,Female,Meningioma,I,Frontal lobe,Radiation,Progressive disease,16.0,Frontal lobe,28
493,46,Female,Astrocytoma,II,Parietal lobe,Surgery,Progressive disease,14.0,Parietal lobe,24
380,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
188,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
764,54,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Partial response,18.0,Occipital lobe,30
217,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
792,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Stable disease,16.0,Occipital lobe,30
1077,56,Female,Meningioma,I,Occipital lobe,Surgery,Complete response,,,38
879,56,Female,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,18.0,Occipital lobe,42
338,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1773,58,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,36
720,60,Female,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Partial response,12.0,Temporal lobe,24
1749,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,12.0,Parietal lobe,24
296,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
1726,58,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Complete response,,,30
1017,66,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,28
1276,49,Male,Astrocytoma,III,Parietal lobe,Chemotherapy,Stable disease,14.0,Parietal lobe,32
1751,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1486,71,Female,Astrocytoma,II,Parietal lobe,Surgery + Chemotherapy,Partial response,20.0,Parietal lobe,42
456,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1997,57,Male,Glioblastoma,IV,Occipital lobe,Surgery,Complete response,,,38
816,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1887,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
270,51,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,36
996,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
202,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
162,52,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,20.0,Temporal lobe,42
1580,50,Female,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,36
730,46,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,42
402,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
703,54,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Stable disease,12.0,Occipital lobe,24
1501,59,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1846,66,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Progressive disease,12.0,Temporal lobe,42
1796,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
1130,50,Male,Glioblastoma,IV,Parietal lobe,Radiation,Partial response,22.0,Parietal lobe,32
566,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
1414,65,Female,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,26.0,Temporal lobe,44
1022,56,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,32
1026,57,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Complete response,,,38
1412,52,Female,Meningioma,I,Frontal lobe,Radiation,Progressive disease,20.0,Frontal lobe,32
1896,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1586,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1105,54,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,16.0,Frontal lobe,28
206,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,24
35,57,Female,Meningioma,I,Temporal lobe,Surgery + Chemotherapy,Complete response,,,72
776,59,Female,Meningioma,I,Occipital lobe,Surgery + Chemotherapy,Complete response,,,30
509,49,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1452,54,Female,Meningioma,I,Frontal lobe,Chemotherapy,Complete response,,,38
1479,55,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,48
1971,66,Male,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,28
1391,54,Male,Astrocytoma,III,Frontal lobe,Chemotherapy,Stable disease,14.0,Frontal lobe,38
92,48,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,12.0,Frontal lobe,30
1364,54,Male,Astrocytoma,III,Parietal lobe,Surgery + Chemotherapy,Stable disease,18.0,Parietal lobe,32
898,53,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,16.0,Parietal lobe,30
565,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
1370,51,Male,Astrocytoma,III,Occipital lobe,Radiation,Progressive disease,16.0,Occipital lobe,28
777,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Partial response,12.0,Temporal lobe,36
242,65,Male,Astrocytoma,III,Frontal lobe,Surgery + Radiation,Progressive disease,18.0,Frontal lobe,42
14,42,Male,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Progressive disease,12.0,Occipital lobe,20
316,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
601,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Stable disease,18.0,Temporal lobe,36
388,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1298,56,Male,Meningioma,I,Occipital lobe,Radiation,Stable disease,20.0,Occipital lobe,32
167,59,Female,Astrocytoma,II,Parietal lobe,Surgery,Partial response,22.0,Parietal lobe,42
841,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
21,53,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Complete response,,,72
647,61,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,48
1843,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
1509,56,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,36
1155,61,Male,Meningioma,I,Frontal lobe,Chemotherapy,Stable disease,20.0,Frontal lobe,28
1529,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
832,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
1268,56,Male,Meningioma,I,Parietal lobe,Surgery + Radiation,Complete response,,,38
1591,51,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Partial response,16.0,Temporal lobe,24
1900,60,Male,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Partial response,20.0,Parietal lobe,30
563,57,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Stable disease,14.0,Temporal lobe,30
1952,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
687,54,Male,Astrocytoma,II,Occipital lobe,Surgery + Chemotherapy,Progressive disease,14.0,Occipital lobe,24
958,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
190,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
1807,61,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,24
976,50,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Complete response,,,36
700,58,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,42
1500,54,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,36
1706,60,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Complete response,,,42
511,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1083,57,Male,Glioblastoma,IV,Occipital lobe,Chemotherapy,Complete response,,,38
475,60,Female,Astrocytoma,III,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
1585,61,Male,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,30
857,55,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Progressive disease,18.0,Frontal lobe,24
748,54,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Complete response,,,36
253,66,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
22,49,Male,Astrocytoma,III,Temporal lobe,Surgery,Partial response,16.0,Temporal lobe,30
1338,54,Male,Astrocytoma,II,Parietal lobe,Chemotherapy,Stable disease,14.0,Parietal lobe,32
460,60,Male,Astrocytoma,III,Temporal lobe,Surgery + Radiation,Progressive disease,18.0,Temporal lobe,42
1185,54,Female,Meningioma,I,Frontal lobe,Surgery + Radiation,Progressive disease,16.0,Frontal lobe,28
277,48,Female,Glioblastoma,IV,Parietal lobe,Surgery + Chemotherapy,Partial response,16.0,Parietal lobe,24
956,46,Female,Meningioma,I,Temporal lobe,Surgery + Radiation,Partial response,18.0,Temporal lobe,42
1216,54,Male,Glioblastoma,IV,Temporal lobe,Surgery + Chemotherapy,Complete response,,,36
386,67,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,42
806,54,Female,Glioblastoma,IV,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,30
1438,61,Female,Meningioma,I,Parietal lobe,Surgery + Chemotherapy,Complete response,,,38
1516,52,Female,Astrocytoma,II,Occipital lobe,Surgery + Radiation,Progressive disease,12.0,Occipital lobe,18
344,58,Male,Meningioma,I,Temporal lobe,Surgery + Radiation,Complete response,,,48
770,65,Female,Meningioma,I,Frontal lobe,Surgery + Chemotherapy,Stable disease,20.0,Frontal lobe,42
1333,48,Female,Meningioma,I,Frontal lobe,Surgery,Progressive disease,16.0,Frontal lobe,28
1686,54,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Complete response,,,36
131,65,Female,Meningioma,I,Parietal lobe,Surgery,Complete response,,,42
1688,48,Female,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Partial response,14.0,Parietal lobe,36
872,48,Male,Astrocytoma,II,Temporal lobe,Surgery + Radiation,Stable disease,16.0,Temporal lobe,42
1124,45,Female,Meningioma,I,Temporal lobe,Radiation,Partial response,20.0,Temporal lobe,44
1397,55,Male,Astrocytoma,III,Occipital lobe,Chemotherapy,Stable disease,14.0,Occipital lobe,44
88,50,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,16.0,Frontal lobe,24
1483,52,Male,Astrocytoma,III,Frontal lobe,Surgery + Chemotherapy,Stable disease,18.0,Frontal lobe,36
331,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1239,64,Female,Meningioma,I,Frontal lobe,Chemotherapy,Progressive disease,16.0,Frontal lobe,28
467,53,Female,Glioblastoma,IV,Occipital lobe,Surgery + Chemotherapy,Partial response,20.0,Occipital lobe,36
122,49,Male,Meningioma,I,Frontal lobe,Surgery,Complete response,,,48
1639,46,Male,Glioblastoma,IV,Temporal lobe,Surgery + Radiation,Stable disease,20.0,Temporal lobe,48
1045,62,Male,Astrocytoma,III,Frontal lobe,Radiation,Stable disease,22.0,Frontal lobe,28
1725,53,Male,Astrocytoma,II,Parietal lobe,Surgery + Radiation,Progressive disease,12.0,Parietal lobe,24
1096,51,Male,Glioblastoma,IV,Temporal lobe,Chemotherapy,Complete response,,,36
1131,59,Female,Astrocytoma,III,Occipital lobe,Surgery,Stable disease,,,38
1295,58,Female,Meningioma,I,Frontal lobe,Surgery,Progressive disease,16.0,Frontal lobe,28
861,52,Female,Glioblastoma,IV,Frontal lobe,Surgery + Chemotherapy,Complete response,14.0,Frontal lobe,24
1460,63,Female,Glioblastoma,IV,Occipital lobe,Surgery + Radiation,Progressive disease,14.0,Occipital lobe,30
1127,60,Female,Meningioma,I,Occipital lobe,Surgery + Radiation,Complete response,,,38
